Andrew Scholey

Professor Andrew Scholey is a leading academic in Human Psychopharmacology at Northumbria University, UK, and holds adjunct positions at Monash and Swinburne Universities in Australia. Previously, he directed the Centre for Human Psychopharmacology at Swinburne University. His research focuses on neurocognitive effects of nutritional interventions, alcohol, and drugs, with an emphasis on cognitive enhancement, mental health, and dietary patterns' impact on brain function.

Education: PhD in Neurosciences from the Open University, BSc (Hons) in Psychology from Plymouth University.

Research Interests: Investigates 'nutra' interventions (nutrients, nutraceuticals), alcohol hangover mechanisms, and translational research to optimize cognitive performance. He has pioneered studies on cocoa flavanols, kava for anxiety, and Mediterranean diet effects on cognition.

Awards & Recognition: Ranked in the top 2% of global scientists by Stanford/Elsevier (2025), with over 300 peer-reviewed publications and £14M+ in research funding. Served on advisory panels for UK Parliament, Canadian Ministry of Health, and Australian Research Council.

Industry Collaboration: Advises global Fortune 500 companies and startups on translating research into evidence-based brain health products. Currently Chief Scientific Officer at Ārepa Nootropics.

Labs & Teams: Leads the Brain Performance and Nutrition Research Centre at Northumbria, established in 2025. Collaborates internationally on projects like the MedWalk Trial (Mediterranean diet and cognitive decline).